Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 4, 2013, Pages 285-291

  De Simone, G ^a,b   Devereux, R B ^a   Roman, M J ^a   Chinali, M ^b   Barac, A ^c   Panza, J A ^c   Lee, E T ^d   Galloway, J M ^e   Howard, B V ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c MEDSTAR RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Coronary disease; Diastolic function; Hypertrophy; Obesity; Risk factors; Systolic function

Indexed keywords

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGED; ALBUMINURIA; AMERICAN INDIAN; ARTICLE; BLOOD; CHI SQUARE DISTRIBUTION; DIABETES MELLITUS; ETHNOLOGY; FEMALE; HEART CONTRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK; RISK ASSESSMENT; RISK FACTOR; TIME; UNITED STATES;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; INDIANS, NORTH AMERICAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; ODDS RATIO; PHENOTYPE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84875062138     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.06.007     Document Type: Article

References (35)

1. Levy D., Larson M.G., Vasan R.S., Kannel W.B., Ho K.K. The progression from hypertension to congestive heart failure. JAMA 1996, 275:1557-1562.
2. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
3. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med 2002, 347:305-313.
4. de Simone G., Devereux R.B., Chinali M., Lee E.T., Galloway J.M., Barac A., et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens 2010, 28:353-360.
5. Devereux R.B., Alderman M.H. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 1993, 88:1444-1455.
6. Devereux R.B., Roman M.J., Paranicas M., O'Grady M.J., Lee E.T., Welty T.K., et al. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 2000, 101:2271-2276.
7. Lee E.T., Fabsitz R., Cowan L.D., Le N.A., Oopik A.J., Cucchiara A.J., et al. The Strong Heart Study - A study of cardiovascular disease in American Indians: Design and methods. Am J Epidemiol 1990, 136:1141-1155.
8. Howard B.V., Lee E.T., Cowan L.D., Fabsitz R.R., Howard W.J., Oopik A.J., et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 1995, 142:254-268.
9. Howard B.V., Lee E.T., Cowan L.D., Devereux R.B., Galloway J.M., Go O.T., et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation 1999, 99:2389-2395.
10. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
11. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R.B., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of echocardiography Committee on standards, Subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
12. de Simone G., Daniels S.R., Devereux R.B., Meyer R.A., Roman M.J., de Divitiis O., et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992, 20:1251-1260.
13. de Simone G., Devereux R.B., Ganau A., Hahn R.T., Saba P.S., Mureddu G.F., et al. Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. Am J Cardiol 1996, 78:801-807.
14. de Simone G., Devereux R.B., Daniels S.R., Mureddu G., Roman M.J., Kimball T.R., et al. Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. Circulation 1997, 95:1837-1843.
15. de Simone G., Devereux R.B., Koren M.J., Mensah G.A., Casale P.N., Laragh J.H. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996, 93:259-265.
16. Stergiopulos N., Meister J.J., Westerhof N. Evaluation of methods for estimation of total arterial compliance. Am J Physiol 1995, 268:H1540-H1548.
17. de Simone G., Roman M.J., Daniels S.R., Mureddu G., Kimball T.R., Greco R., et al. Age-related changes in total arterial capacitance from birth to maturity in a normotensive population. Hypertension 1997, 29:1213-1217.
18. Bella J.N., Palmieri V., Roman M.J., Liu J.E., Welty T.K., Lee E.T., et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 2002, 105:1928-1933.
19. Tsang T.S., Gersh B.J., Appleton C.P., Tajik A.J., Barnes M.E., Bailey K.R., et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002, 40:1636-1644.
20. Chinali M., de Simone G., Roman M.J., Bella J.N., Liu J.E., Lee E.T., et al. Left atrial systolic force and cardiovascular outcome the Strong Heart Study. Am J Hypertens 2005, 18:1570-1576.
21. Satagopan J.M., Ben Porat L., Berwick M., Robson M., Kutler D., Auerbach A.D. A note on competing risks in survival data analysis. Br J Cancer 2004, 91:1229-1235.
22. Schmiedel O., Schroeter M.L., Harvey J.N. Microalbuminuria in Type 2 diabetes indicates impaired microvascular vasomotion and perfusion. Am J Physiol - Heart Circulatory Physiol 2007, 293:H3424-H3431.
23. Kilpatrick E.S., Dominiczak M.H., Small M. The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetes. QJM 1996, 89:307-312.
24. Maru S., Koch G.G., Stender M., Clark D., Gibowski L., Petri H., et al. Antidiabetic Drugs and heart failure risk in patients with type 2 diabetes in the U.K. Primary Care Setting. Diabetes Care 2005, 28:20-26.
25. Nathan D.M. Rosiglitazone and cardiotoxicity-weighing the evidence. N Engl J Med 2007, 357:64-66.
26. de Simone G., Gottdiener J.S., Chinali M., Maurer M.S. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 2008, 29:741-747.
27. Nemes A., Forster T., Lengyel C., Csanady M. Reduced aortic distensibility and coronary flow velocity reserve in diabetes mellitus patients with a negative coronary angiogram. Can J Cardiol 2007, 23:445-450.
28. Cortigiani L., Rigo F., Gherardi S., Sicari R., Galderisi M., Bovenzi F., et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007, 50:1354-1361.
29. Galderisi M., de Simone G., D'Errico A., Sidiropulos M., Viceconti R., Chinali M., et al. Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension. Am J Hypertens 2008, 21:1040-1046.
30. Thompson E.W. Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement. Proc Soc Exp Biol Med 1994, 205:294-305.
31. Akula A., Kota M.K., Gopisetty S.G., Chitrapu R.V., Kalagara M., Kalagara S., et al. Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats. Pharmacol Res 2003, 48:429-435.
32. Loganathan R., Bilgen M., Al-Hafez B., Smirnova I.V. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging 2006, 22:81-90.
33. van Heerebeek L., Hamdani N., Handoko M.L., Falcao-Pires I., Musters R.J., Kupreishvili K., et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008, 117:43-51.
34. Desrois M., Sidell R.J., Gauguier D., King L.M., Radda G.K., Clarke K. Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. Cardiovasc Res 2004, 61:288-296.
35. An D., Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006, 291:H1489-H1506.